site stats

Intellia pharmaceuticals stock

Nettet6. des. 2024 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Nettet14. jul. 2024 · During the first quarter of 2024, Intellia reported total operating expenses of about $46 million and a net loss of $31.8 million. The company had $250.3 million in …

Intellia Therapeutics Shares Soar 12% on Positive Analyst Rating …

Nettet1. jul. 2024 · Intellia Therapeutics stock declined 4.0% the last twenty-one trading days (one month), compared to a broader market (S&P500) rise of 1.1%. A change of -4% or more over twenty-one trading days is ... Nettet13. apr. 2024 · Intellia Therapeutics Stock Performance. 3 Mid-Caps That Could Double in 2024; Shares of NTLA opened at $34.58 on Thursday. The stock has a fifty day moving average price of $39.20 and a 200 day moving average price of $43.29. Intellia Therapeutics, Inc. has a 12 month low of $32.44 and a 12 month high of $76.45. learn to trade the stock market https://boxh.net

What’s Next For Alnylam Stock After The Recent Positive ... - Forbes

NettetIntellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed S&P 500 +14.64 Dow 30 33,485.29 +2.57(+0.01%) Nasdaq 12,087.96 +91.09(+0.76%) Russell... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo … Discover historical prices for NTLA stock on Yahoo Finance. View daily, weekly or … Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and … Find out the direct holders, institutional holders and mutual fund holders for … See Intellia Therapeutics, Inc. (NTLA) Environment, Social and Governance … See the company profile for Intellia Therapeutics, Inc. (NTLA) including … The latest news and headlines from Yahoo! News. Get breaking news stories and in … See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings … Nettet24. mar. 2024 · Intellia Therapeutics (NASDAQ: NTLA) is a biotechnology company using CRISPR gene-editing technology to develop several experimental drugs, many of with having the potential to save countless lives. As a relatively new drug development technology, Intellia is one of several companies at the forefront of CRISPR-based drug … Nettet12/19/21 NTLA Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) Sector: Health Technology (Biotechnology) Market Capitalization: 9.545B Current Price: $128.23 Breakout price: $125.25 (hold above) Buy Zone (Top/Bottom Range): $118.80-$110.25 Price Target: $170.00-$174.00 Estimated Duration to Target: 84-90d Contract Intellia Therapeutics, … how to do order of operation math

Gene editing stocks rally as Wall Street turns bullish

Category:Stock Information - Intellia Therapeutics

Tags:Intellia pharmaceuticals stock

Intellia pharmaceuticals stock

Intellia Therapeutics - NTLA Stock Forecast, Price & News - MarketBeat

Nettet9. apr. 2024 · By selling US$762k worth of Intellia Therapeutics, Inc. (NASDAQ:NTLA) stock at an average sell price of US$37.61 over the last year, insiders seemed to have made the most of their holdings.After the stock price dropped 3.5% last week, the company's market value declined by US$115m, but insiders were able to mitigate their … NettetFind real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, ... Pharmaceuticals: Major. No executives to display. Corporate headquarters. Cambridge, Massachusetts.

Intellia pharmaceuticals stock

Did you know?

Nettet15. apr. 2024 · Intellia Therapeutics’ approach has received In addition, the company has several licensing agreements with CRISPR Therapeutics, Abbott, and Microsoft. Skip to … Nettet12. apr. 2024 · Intellia Therapeutics - NTLA Stock Forecast, Price & News $35.96 +0.17 (+0.47%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $35.13 $36.36 50 …

Nettet8. apr. 2024 · Summary of all time highs, changes and price drops for Intellia Therapeutics; Historical stock prices; Current Share Price: US$35.96: 52 Week High: … Nettetfor 1 dag siden · All seven stocks have lost more than 20% over the past 12 months compared to a ~12% slump in the broader biotech sector. Verve ( VERV) and Intellia ( NTLA) rallied after Canaccord Genuity ...

Nettet12. apr. 2024 · 04/11/2024. Intellia Therapeutics stock price stood at $35.31. According to the latest long-term forecast, Intellia Therapeutics price will hit $45 by the end of 2024 and then $70 by the end of 2024. Intellia Therapeutics will rise to $85 within the year of 2025, $100 in 2026, $125 in 2027 and $150 in 2029. NettetFind real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. NTLA - Intellia Therapeutics Inc Stock quote - …

Nettet6. apr. 2024 · Intellia's stock jumps as CRISPR therapy moves into Phase 2 clinical trial. Shares of Intellia Therapeutics Inc. NTLA, +1.44% rallied about 10% in premarket …

NettetNTLA: Get the latest Intellia Therapeutics stock price and detailed information including NTLA news, ... Regeneron Pharmaceuticals, Inc. 4.34: Nikko Asset Management … learn to travel on budgetNettet31. mar. 2024 · Intellia Therapeutics Inc. is currently in a neutral trading position according to technical analysis indicators. More on Technical Analysis Valuation Technicals Institutional Holdings ARK Investment Management LLC 10.7% Vanguard Group Inc 8.87% BlackRock Inc 8.24% State Street Corporation 4.27% Sumitomo Mitsui Trust … how to do order raidNettet24. feb. 2024 · CAMBRIDGE, Mass., Feb. 24, 2024 - Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today reported operational highlights and financial results for the fourth quarter and year ended December 31, 2024. how to do order of operationNettet12. apr. 2024 · Intellia Therapeutics - NTLA Stock Forecast, Price & News $35.96 +0.17 (+0.47%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $35.13 $36.36 50-Day Range $35.79 $44.82 52-Week Range $32.44 $76.45 Volume 804,840 shs Average Volume 1.13 million shs Market Capitalization $3.17 billion P/E Ratio N/A … how to do ordinal logistic regression in spssNettet29. jun. 2024 · Shares of Intellia Therapeutics, Inc. NTLA were up 50.21% on Monday after the company, along with its partner Regeneron Pharmaceuticals REGN, announced positive interim data from the ongoing... learn to tune cars freeNettetfor 1 dag siden · Le azioni di Intellia Therapeutics sono salite dopo che Canaccord Genuity ha iniziato la copertura con un rating buy (acquistare) MT. 13/04. Intellia Therapeutics, Inc.: Canaccord Genuity è per il Buy. MM. 07/04. Intellia Therapeutics, Inc.: RBC Capital Markets conferma il rating Buy. MM. how to do orders wowNettetThe Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts. Skip to main navigation About . Who We ... Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Data Provided by … how to do ordinary numbers